212 related articles for article (PubMed ID: 26614034)
1. Current Clinical Applications of Testicular Cancer Biomarkers.
Mir MC; Pavan N; Gonzalgo ML
Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Biomarkers for Germ Cell Tumors.
Nappi L; Nichols C
Urol Clin North Am; 2019 Aug; 46(3):449-457. PubMed ID: 31277739
[TBL] [Abstract][Full Text] [Related]
3. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?
Belge G; Dieckmann KP; Spiekermann M; Balks T; Bullerdiek J
Eur Urol; 2012 May; 61(5):1068-9. PubMed ID: 22386195
[No Abstract] [Full Text] [Related]
5. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Ling H; Krassnig L; Bullock MD; Pichler M
Urol Clin North Am; 2016 Feb; 43(1):127-34. PubMed ID: 26614035
[TBL] [Abstract][Full Text] [Related]
7. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
9. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
10. Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?
Henrique R; Jerónimo C
Eur Urol; 2017 Feb; 71(2):221-222. PubMed ID: 27543167
[No Abstract] [Full Text] [Related]
11. Testicular cancer: a new generation of biomarkers for malignant germ cell tumours.
Murray MJ; Coleman N
Nat Rev Urol; 2012 May; 9(6):298-300. PubMed ID: 22549310
[No Abstract] [Full Text] [Related]
12. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
[TBL] [Abstract][Full Text] [Related]
13. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?
Spiekermann M; Dieckmann KP; Balks T; Bullerdiek J; Belge G
Anticancer Res; 2015 Jan; 35(1):117-21. PubMed ID: 25550541
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
Egan J; Salari K
Urol Clin North Am; 2023 Feb; 50(1):133-143. PubMed ID: 36424077
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers in the evaluation of male germ cell tumors.
Barlow LJ; Badalato GM; McKiernan JM
Nat Rev Urol; 2010 Nov; 7(11):610-7. PubMed ID: 21068762
[TBL] [Abstract][Full Text] [Related]
16. Consensus statement on circulating tumour markers and staging patients with germ cell tumours.
Rustin GJ; Vogelzang NJ; Sleijfer DT; Nisselbaum JN
Prog Clin Biol Res; 1990; 357():277-84. PubMed ID: 2170994
[No Abstract] [Full Text] [Related]
17. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of Trace Elements in Patients with Testicular Cancers.
Kaba M; Pirinççi N; Yüksel MB; Gecit İ; Güneş M; Demir M; Akkoyun H; Demir H
Int Braz J Urol; 2015; 41(6):1101-7. PubMed ID: 26742967
[TBL] [Abstract][Full Text] [Related]
19. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis.
Crawford SM; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
Br J Urol; 1988 Mar; 61(3):250-3. PubMed ID: 2833974
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer.
Hauser S; Kaminski A; Syring I; Holdenrieder S; Dieckmann KP; Muller SC; Ellinger J
In Vivo; 2019; 33(6):1935-1940. PubMed ID: 31662522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
